Understanding the timeline — and why it matters
Ozempic (semaglutide) is one of the most prescribed medications in Canada right now, and also one of the most frequently misunderstood. Patients starting treatment often expect immediate dramatic results — and when the first few weeks feel underwhelming, some stop before the medication has had a real chance to work.
The reality is that Ozempic operates on multiple distinct timelines for different effects. Appetite changes appear within the first couple of weeks. Measurable weight loss generally begins in weeks four to eight. Meaningful results — in the clinical sense — typically accumulate over months three through six. Knowing this upfront is often what separates patients who continue through the critical early phase and ultimately succeed from those who quit too soon.
Weeks 1–2: The appetite shift begins
Most patients notice some degree of appetite suppression within the first one to two weeks, even at the starting dose of 0.25mg. You may find that meals feel more satisfying, that food cravings are quieter, or that you simply stop thinking about food between meals. These are early signs that the medication is working as intended.
Semaglutide works by mimicking GLP-1, a hormone your body naturally produces after eating. GLP-1 signals the brain that you are full, slows gastric emptying, and reduces the urgency of hunger signals. At 0.25mg, the dose is intentionally low — this phase is about acclimation, not maximum effect.
Side effects are most common during these first two weeks: mild nausea, occasional constipation, or a general feeling of digestive sluggishness. These are nearly universal and typically fade as the body adjusts. Eating smaller meals, staying hydrated, and avoiding high-fat foods at injection time helps substantially. Most patients who push through this phase comfortably find that side effects are minimal by week three.
Weeks 4–8: Dose escalation and measurable loss
After four weeks at the starting dose, the standard protocol moves to 0.5mg. Appetite suppression strengthens noticeably at this level, and most patients begin experiencing measurable weight loss — typically in the range of 1 to 2 lbs per week, depending on diet, activity level, and starting weight.
This is the phase where most patients first feel that the medication is genuinely working. The reduction in appetite is no longer subtle — meals feel physically satisfying at smaller portions, and the mental noise around food (constant thinking about the next meal, strong cravings, difficulty stopping once eating) quiets meaningfully for most people.
It is also the phase where lifestyle choices matter most. Ozempic is not a passive intervention. It creates a biological window in which eating less and moving more becomes substantially easier — but the choices still belong to the patient. Those who use this window to build better eating patterns and increase activity will see meaningfully better results than those who simply wait for the scale to move.
Months 3–6: Meaningful clinical results
By the three-month mark, patients on a well-managed semaglutide program have typically lost 5–8% of their starting body weight. For someone beginning at 220 lbs, that's roughly 11–18 lbs. Results vary, but this range is consistent with clinical trial data and real-world outcomes at Acme Drug Mart.
By month six, clinical trials show average weight loss of approximately 10–15% of starting body weight at therapeutic doses. For the STEP 1 trial (Wegovy, which uses a higher dose of semaglutide), participants lost an average of 14.9% over 68 weeks. These are among the most significant weight loss outcomes ever demonstrated in a pharmaceutical context.
It is worth noting that individuals vary considerably. Some patients respond more dramatically; others less so. Medical history, starting weight, diet quality, activity level, and how consistently the medication is taken all influence outcomes. Your pharmacist will track your progress and help you understand whether titration is appropriate or whether the current dose is the right fit.
Plateaus and long-term maintenance
Most patients experience a plateau somewhere between months six and twelve. The body establishes a new equilibrium at the lower weight, and loss slows or stops. This is not failure — it is physiology. The medication has done what it can at its current dose, and the question becomes whether further titration makes sense or whether the focus should shift to consolidating and maintaining current results.
One important long-term consideration: weight typically returns within six to twelve months of stopping Ozempic if lifestyle changes have not been solidified during treatment. The medication addresses hunger signals; it does not permanently alter the underlying biology. Patients who use the treatment period to build lasting changes in how they eat and move have considerably better long-term outcomes than those who view the medication as a temporary course.
What your pharmacist monitors
Managing an Ozempic program involves more than dispensing a refill once a month. At Acme Drug Mart, our pharmacist actively monitors patients on GLP-1 medications for:
- Drug interactions — particularly relevant for patients on diabetes medications, blood pressure medications, or other drugs that may require dose adjustment as body weight changes
- Side-effect patterns that suggest the current dose needs adjustment
- Injection technique — improper site rotation or injection depth can affect absorption and increase local side effects
- Progress toward goals and discussion of dose titration timing
These are services that telehealth-only platforms cannot provide. Acme Drug Mart carries Ozempic, Wegovy, Mounjaro, Saxenda, and Contrave, and our pharmacist has direct clinical experience with all of them.
Common side effects
The most frequently reported side effects across all GLP-1 medications are gastrointestinal: nausea, stomach discomfort, constipation, or loose stools. These are dose-dependent — they tend to be most pronounced immediately after a dose increase and typically fade within one to two weeks at each new level. Rare but more serious side effects include pancreatitis and gallbladder disease; your pharmacist and prescribing physician will screen for relevant risk factors.
What to do about a missed dose
Ozempic is injected once weekly. If you miss a dose:
- Within 5 days of the missed dose: Take it as soon as you remember, then resume your regular schedule.
- More than 5 days after the missed dose: Skip the missed dose entirely and resume your regular weekly schedule on the next scheduled day. Do not double-dose.
If you are frequently missing doses, talk to your pharmacist about whether a different injection day or a reminder system would help. Consistency is important for both effectiveness and tolerance.
Questions about your Ozempic program?
Our pharmacist is here to help — whether you're just starting, experiencing side effects, or thinking about switching medications. We carry all major GLP-1 options.
Call (780) 443-0202This article is for informational purposes only and does not constitute medical advice. Weight loss medication programs require clinical assessment and ongoing monitoring. Individual results vary. Consult a qualified healthcare provider for guidance specific to your situation.